Osyris Medical, a laser medical company, has received the US Food and Drug Administration (FDA) clearance for its Lipocontrol system for laser assisted lipolysis.

The Lipocontrol is the latest generation of 980nm diode designed to be a workhorse in the operating room for laser assisted lipolysis.

The Lipocontrol offers real time Energy Mapping technology with motion sensing and Energy Memory features included.

The Osyris’ patented technology offers the physician the highest level of control and safety available in market.

Osyris Medical R&D vice president Philippe Rochon said they are glad to bring the new device into the US market.

"In the current regulatory framework, in which several manufacturers are facing difficulties in the 510(k) process, the clearance of such product tends to emphasize the technological breakthrough made by Osyris Medical with the Lipocontrol," Rochon said.